Kopran Limited — JV/Acquisition, 18-04-2025: Amalgamation/Merger

Kopran Limited has initiated a scheme for the amalgamation of Kopran Laboratories Limited into itself, aiming to streamline operations and reduce regulatory burdens. This merger is set to enhance operational efficiencies and create a more cohesive organizational structure, enabling better resource pooling and cost management. The merger will facilitate shared capabilities, particularly in manufacturing healthcare products, thereby increasing profitability. Shareholders of Kopran Laboratories will receive 100 equity shares of Kopran Limited for every 45 shares held, enhancing shareholder value and enhancing liquidity as the newly merged entity will be listed on stock exchanges. The appointed date for the merger is January 1, 2025, with expectations of significant synergies.